Surgical ENT Devices Market Consumption and Revenue Forecast by Regions 2030

Surgical ENT Device Market Growth & Trends

The global surgical ENT devices market size is expected to reach USD 11.2 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.77% from 2023 to 2030. The high prevalence of hearing loss, increasing uptake of surgeries for the treatment of ENT disorders, and the availability of advanced surgical devices are certain factors positively impacting the market growth.

U.S. surgical ENT devices market size, by product, 2020 - 2030 (USD Billion)

Surgical ENT Device Market Segmentation

Grand View Research has segmented the global surgical ENT devices market based on product and region:

Based on the Product Insights, the market is segmented into Radiofrequency Handpieces, Sinus Stents, Powered Surgical Instruments, Rigid Endoscopes, Sinus Balloon Dilation Devices, Otological Drill Burrs, ENT Hand Instruments, Tympanostomy Tubes, Nasal Packing Devices.

  • In the current scenario, merger and acquisition activity in the ENT devices sector has reduced significantly. There have been several deals as market players boost their technical capabilities. The radiofrequency handpieces segment held the largest revenue share of over 22.6% in 2022. These are medical devices, which coupled with pre-existing legacy RF signal generator systems, provide certain precision-controlled radiofrequency therapies and treatments for ear, nose, and throat. For instance, the handpiece from Ellman International, Inc. is designed to fit comfortably in an operator’s hand, therefore, maximizing productivity by reducing operator fatigue and discomfort. It is easy to use and can be used across fields of ENT surgery.
  • Surgical ENT devices are mainly used for treating, diagnosing, or conducting surgeries for disorders of the ear, nose, and throat. These devices help in treating issues related to snoring, speaking, hearing, or smell, and a broad range of surgical ENT devices is available in the market. Growing preference for minimally invasive surgeries and the increasing prevalence of ENT disorders are expected to impel market growth in the coming years.
  • The sinus balloon dilation devices market is expected to register the fastest CAGR of 6.0 % during the forecast period. Applications of dilation devices in providing ease of treating prevalent ENT conditions such as Sinusitis are expectedto majorly contribute to the demand for these devices. However, the shortage of skilled ENT surgeons and otolaryngologists is a major challenge to the growth of the market.

Surgical ENT Devices Regional Outlook

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Market Share Insights

  • April 2021: Recent launches include H-SteriScope, a line of five single-use endoscopes by Olympus Corporation
  • September 2021: Recent launches also include a software solution for TruDi Navigation System by Johnson & Johnson

Key Companies Profile & Market Share Insights

The market is evolving and becoming increasingly competitive in terms of R&D activities regarding the assessment of the existing products for efficiency, along with the launch of new products and marketing for payers.

Some of the prominent players operating in the global surgical ENT devices market include,

  • Medtronic plc
  • Olympus Corporation
  • Richard Wolf GmbH
  • ZEISS Group
  • Stryker
  • Smith & Nephew
  • Johnson & Johnson
  • Integra LifeSciences
  • HOYA Corporation
  • Sonova

Order a free sample PDF of the Surgical ENT Devices Market Intelligence Study, published by Grand View Research.

Comments

Popular posts from this blog

India Electric Vehicle Market Competitive Landscape Report to 2028

Automotive Semiconductor Market Share, Drivers And Restraints By 2028

LiDAR Market Historical Data & Forecasts 2030